Recombinant Human CD5L (C-6His)

Catalog Number: EBT-EPT306
Article Name: Recombinant Human CD5L (C-6His)
Biozol Catalog Number: EBT-EPT306
Supplier Catalog Number: EPT306
Alternative Catalog Number: EBT-EPT306-10
Manufacturer: ELK Biotechnology
Category: Proteine/Peptide
Alternative Names: CD5 Antigen-Like, CT-2, IgM-Associated Peptide, SP-Alpha, CD5L, API6
Recombinant Human CD5 Antigen-Like is produced by our Mammalian expression system and the target gene encoding Ser20-Gly347 is expressed with a 6His tag at the C-terminus.
Molecular Weight: Molecular weight: 37.09 KDa. Apparent molecular weight: 38-50 KDa, reducing conditions
UniProt: O43866
Purity: Greater than 95% as determined by reducing SDS-PAGE.
Application Notes: Redissolve: Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100µg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.. Endotoxin: Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. Background: CD5 Antigen-Like (CD5L) is a soluble protein that belongs to group B of the scavenger receptor cysteine-rich (SRCR) superfamily and contains three SRCR domains. CD5L is a secreted glycoprotein and expressed by macrophages presentin lymphoid tissues. It binds to myelomonocytic and lymphoid cells and may play an important role in the regulation of the innate and adaptive immune systems. CD5L functions as a pattern recognition molecule by binding both lipoteichoic acid (LTA) on Gram positive and lipopolysaccharide (LPS) on Gram-negative bacteria and the SRCR domain one of CD5L retains both the LPS and LTA binding activities. Furthermore, CD5L seems to play a role as an inhibitor of apoptosis